Aged 14 to 16

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Aged 14 to 16 trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT05808166

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

This is a phase II randomized, observer-blinded, placebo-controlled study with 3 arms enrolling a total of 2,358 participants. The arms are composed of Arm 1, p…

Pakistan2,358 participantsStarted 2024-05-02

Treatment: Hecolin® (Recombinant Hepatitis E Vaccine (Escherichia coli))., Isotonic Sodium Chloride injection

All recent trials (4 shown)

By InvitationNot Applicable

NCT06719752

Assessing the Acute Effects of Diagonal Mobilization

Investigating the acute effects of mobilization on these parameters offers innovative insights for the practitioner community and sheds light on the strategy's…

Poland50 participantsStarted 2025-02-25

Treatment: Placebo

CompletedPhase 2

NCT02740777

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

To evaluate the immune non-inferiority, as measured by antibody responses, of a 2-dose immunization schedule (0, 6 months) of recombinant human papillomavirus v…

China900 participantsStarted 2016-02

Treatment: HPV-16/18 vaccine

Aged 14 to 16

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

All recent trials (4 shown)

Assessing the Acute Effects of Diagonal Mobilization

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Safety and Immunogenicity of Hecolin® in Healthy Pregnant Women

All recent trials (4 shown)

Assessing the Acute Effects of Diagonal Mobilization

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Persistence of Immune Response After Vaccination With MCC